Long-Term Risks To Statin Sales? (MRK, PFE, AZN)

[24/7 Wall St.]

24/7 Wall St. Daily News

We have run a full feature story over at BioHealthInvestor.com after reading a study that came off the Mayo Clinic site. The study showed that a combination of fish oil and red rice yeast in combination along with a 12-week multidisciplinary lifestyle program generated much of the same results as a statin alone in lowering LDL Cholesterol. Stocks we covered in this include Merck & Co. (NYSE: MRK), Pfizer Inc. (NYSE: PFE) and AstraZeneca plc (NYSE: AZN). There are many others which could have been included, but this study went head to head with Merck's Zocor (off of exclusivity). It...http://feeds.feedburner.com/~f/typepad/RyNm?i=YiCTlJ</img> (http://feeds.feedburner.com/~f/typepad/RyNm?a=YiCTlJ) http://feeds.feedburner.com/~f/typepad/RyNm?i=K7cHwJ</img> (http://feeds.feedburner.com/~f/typepad/RyNm?a=K7cHwJ) http://feeds.feedburner.com/~f/typepad/RyNm?i=XCANyj</img> (http://feeds.feedburner.com/~f/typepad/RyNm?a=XCANyj)


complete story here... (http://www.247wallst.com/2008/07/long-term-risks.html)